APO Research

APO RESEARCH · REPORT

Prostaglandin I2

Selected research

Market Analysis & Forecast

Global Prostaglandin I2 Market Analysis and Forecast 2026-2032

Market perspective

The global Prostaglandin I2 market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Prostaglandin I2 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Prostaglandin I2 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Prostaglandin I2 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Prostaglandin I2 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Prostaglandin I2 include Teva, J & J, GSK, Bayer AG, United Therapeutics, Toray and Tide Pharma, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Prostaglandin I2, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Prostaglandin I2, also provides the sales of main regions and countries. Of the upcoming market potential for Prostaglandin I2, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Prostaglandin I2 sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Prostaglandin I2 market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Prostaglandin I2 sales, projected growth trends, production technology, application and end-user industry.

Prostaglandin I2 Segment by Company

Teva

J & J

GSK

Bayer AG

United Therapeutics

Toray

Tide Pharma

Prostaglandin I2 Segment by Type

Epoprostenol Sodium

Iloprost

Treprostinil

Beraprost Sodium

Prostaglandin I2 Segment by Application

For Oral

For Inhalation

For Injection

Prostaglandin I2 Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prostaglandin I2 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Prostaglandin I2 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prostaglandin I2.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Prostaglandin I2 in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Prostaglandin I2 manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Prostaglandin I2 sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Prostaglandin I2 Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Epoprostenol Sodium Major Manufacturers Table 3. Iloprost Major Manufacturers Table 4. Treprostinil Major Manufacturers Table 5. Beraprost Sodium Major Manufacturers Table 6. Global Prostaglandin I2 Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. For Oral Major Manufacturers Table 8. For Inhalation Major Manufacturers Table 9. For Injection Major Manufacturers Table 10. Prostaglandin I2 Industry Trends Table 11. Prostaglandin I2 Industry Drivers Table 12. Prostaglandin I2 Industry Opportunities and Challenges Table 13. Prostaglandin I2 Industry Restraints Table 14. Global Prostaglandin I2 Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Prostaglandin I2 Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Prostaglandin I2 Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Prostaglandin I2 Revenue Market Share by Region (2021-2026) Table 18. Global Prostaglandin I2 Revenue Market Share by Region (2027-2032) Table 19. Global Prostaglandin I2 Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 20. Global Prostaglandin I2 Sales by Region (2021-2026) & (k units) Table 21. Global Prostaglandin I2 Sales by Region (2027-2032) & (k units) Table 22. Global Prostaglandin I2 Sales Market Share by Region (2021-2026) Table 23. Global Prostaglandin I2 Sales Market Share by Region (2027-2032) Table 24. Global Prostaglandin I2 Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Prostaglandin I2 Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Prostaglandin I2 Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Prostaglandin I2 Sales Market Share by Manufacturers (2021-2026) Table 28. Global Prostaglandin I2 Sales Price (US$/unit) of Manufacturers (2021-2026) Table 29. Global Prostaglandin I2 Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Prostaglandin I2 Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Prostaglandin I2 Manufacturers, Product Type & Application Table 32. Global Prostaglandin I2 Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Prostaglandin I2 by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Prostaglandin I2 Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Prostaglandin I2 Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Prostaglandin I2 Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Prostaglandin I2 Revenue Market Share by Type (2021-2026) Table 39. Global Prostaglandin I2 Revenue Market Share by Type (2027-2032) Table 40. Global Prostaglandin I2 Sales by Type 2021 VS 2025 VS 2032 (k units) Table 41. Global Prostaglandin I2 Sales by Type (2021-2026) & (k units) Table 42. Global Prostaglandin I2 Sales by Type (2027-2032) & (k units) Table 43. Global Prostaglandin I2 Sales Market Share by Type (2021-2026) Table 44. Global Prostaglandin I2 Sales Market Share by Type (2027-2032) Table 45. Global Prostaglandin I2 Price by Type (2021-2026) & (US$/unit) Table 46. Global Prostaglandin I2 Price by Type (2027-2032) & (US$/unit) Table 47. Global Prostaglandin I2 Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Prostaglandin I2 Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Prostaglandin I2 Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Prostaglandin I2 Revenue Market Share by Application (2021-2026) Table 51. Global Prostaglandin I2 Revenue Market Share by Application (2027-2032) Table 52. Global Prostaglandin I2 Sales by Application 2021 VS 2025 VS 2032 (k units) Table 53. Global Prostaglandin I2 Sales by Application (2021-2026) & (k units) Table 54. Global Prostaglandin I2 Sales by Application (2027-2032) & (k units) Table 55. Global Prostaglandin I2 Sales Market Share by Application (2021-2026) Table 56. Global Prostaglandin I2 Sales Market Share by Application (2027-2032) Table 57. Global Prostaglandin I2 Price by Application (2021-2026) & (US$/unit) Table 58. Global Prostaglandin I2 Price by Application (2027-2032) & (US$/unit) Table 59. Teva Company Information Table 60. Teva Business Overview Table 61. Teva Prostaglandin I2 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 62. Teva Prostaglandin I2 Product Portfolio Table 63. Teva Recent Development Table 64. J & J Company Information Table 65. J & J Business Overview Table 66. J & J Prostaglandin I2 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 67. J & J Prostaglandin I2 Product Portfolio Table 68. J & J Recent Development Table 69. GSK Company Information Table 70. GSK Business Overview Table 71. GSK Prostaglandin I2 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 72. GSK Prostaglandin I2 Product Portfolio Table 73. GSK Recent Development Table 74. Bayer AG Company Information Table 75. Bayer AG Business Overview Table 76. Bayer AG Prostaglandin I2 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Bayer AG Prostaglandin I2 Product Portfolio Table 78. Bayer AG Recent Development Table 79. United Therapeutics Company Information Table 80. United Therapeutics Business Overview Table 81. United Therapeutics Prostaglandin I2 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. United Therapeutics Prostaglandin I2 Product Portfolio Table 83. United Therapeutics Recent Development Table 84. Toray Company Information Table 85. Toray Business Overview Table 86. Toray Prostaglandin I2 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. Toray Prostaglandin I2 Product Portfolio Table 88. Toray Recent Development Table 89. Tide Pharma Company Information Table 90. Tide Pharma Business Overview Table 91. Tide Pharma Prostaglandin I2 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. Tide Pharma Prostaglandin I2 Product Portfolio Table 93. Tide Pharma Recent Development Table 94. North America Prostaglandin I2 Revenue by Type (2021-2026) & (US$ Million) Table 95. North America Prostaglandin I2 Revenue by Type (2027-2032) & (US$ Million) Table 96. North America Prostaglandin I2 Sales by Type (2021-2026) & (k units) Table 97. North America Prostaglandin I2 Sales by Type (2027-2032) & (k units) Table 98. North America Prostaglandin I2 Sales Price by Type (2021-2026) & (US$/unit) Table 99. North America Prostaglandin I2 Sales Price by Type (2027-2032) & (US$/unit) Table 100. North America Prostaglandin I2 Revenue by Application (2021-2026) & (US$ Million) Table 101. North America Prostaglandin I2 Revenue by Application (2027-2032) & (US$ Million) Table 102. North America Prostaglandin I2 Sales by Application (2021-2026) & (k units) Table 103. North America Prostaglandin I2 Sales by Application (2027-2032) & (k units) Table 104. North America Prostaglandin I2 Sales Price by Application (2021-2026) & (US$/unit) Table 105. North America Prostaglandin I2 Sales Price by Application (2027-2032) & (US$/unit) Table 106. North America Prostaglandin I2 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 107. North America Prostaglandin I2 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 108. North America Prostaglandin I2 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 109. North America Prostaglandin I2 Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 110. North America Prostaglandin I2 Sales by Country (2021-2026) & (k units) Table 111. North America Prostaglandin I2 Sales by Country (2027-2032) & (k units) Table 112. North America Prostaglandin I2 Sales Price by Country (2021-2026) & (US$/unit) Table 113. North America Prostaglandin I2 Sales Price by Country (2027-2032) & (US$/unit) Table 114. United States Prostaglandin I2 Revenue (2021-2032) & (US$ Million) Table 115. Canada Prostaglandin I2 Revenue (2021-2032) & (US$ Million) Table 116. Mexico Prostaglandin I2 Revenue (2021-2032) & (US$ Million) Table 117. Europe Prostaglandin I2 Revenue by Type (2021-2026) & (US$ Million) Table 118. Europe Prostaglandin I2 Revenue by Type (2027-2032) & (US$ Million) Table 119. Europe Prostaglandin I2 Sales by Type (2021-2026) & (k units) Table 120. Europe Prostaglandin I2 Sales by Type (2027-2032) & (k units) Table 121. Europe Prostaglandin I2 Sales Price by Type (2021-2026) & (US$/unit) Table 122. Europe Prostaglandin I2 Sales Price by Type (2027-2032) & (US$/unit) Table 123. Europe Prostaglandin I2 Revenue by Application (2021-2026) & (US$ Million) Table 124. Europe Prostaglandin I2 Revenue by Application (2027-2032) & (US$ Million) Table 125. Europe Prostaglandin I2 Sales by Application (2021-2026) & (k units) Table 126. Europe Prostaglandin I2 Sales by Application (2027-2032) & (k units) Table 127. Europe Prostaglandin I2 Sales Price by Application (2021-2026) & (US$/unit) Table 128. Europe Prostaglandin I2 Sales Price by Application (2027-2032) & (US$/unit) Table 129. Europe Prostaglandin I2 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 130. Europe Prostaglandin I2 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 131. Europe Prostaglandin I2 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 132. Europe Prostaglandin I2 Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 133. Europe Prostaglandin I2 Sales by Country (2021-2026) & (k units) Table 134. Europe Prostaglandin I2 Sales by Country (2027-2032) & (k units) Table 135. Europe Prostaglandin I2 Sales Price by Country (2021-2026) & (US$/unit) Table 136. Europe Prostaglandin I2 Sales Price by Country (2027-2032) & (US$/unit) Table 137. Germany Prostaglandin I2 Revenue (2021-2032) & (US$ Million) Table 138. France Prostaglandin I2 Revenue (2021-2032) & (US$ Million) Table 139. U.K. Prostaglandin I2 Revenue (2021-2032) & (US$ Million) Table 140. Italy Prostaglandin I2 Revenue (2021-2032) & (US$ Million) Table 141. Russia Prostaglandin I2 Revenue (2021-2032) & (US$ Million) Table 142. Spain Prostaglandin I2 Revenue (2021-2032) & (US$ Million) Table 143. Netherlands Prostaglandin I2 Revenue (2021-2032) & (US$ Million) Table 144. Switzerland Prostaglandin I2 Revenue (2021-2032) & (US$ Million) Table 145. Sweden Prostaglandin I2 Revenue (2021-2032) & (US$ Million) Table 146. Poland Prostaglandin I2 Revenue (2021-2032) & (US$ Million) Table 147. China Prostaglandin I2 Revenue by Type (2021-2026) & (US$ Million) Table 148. China Prostaglandin I2 Revenue by Type (2027-2032) & (US$ Million) Table 149. China Prostaglandin I2 Sales by Type (2021-2026) & (k units) Table 150. China Prostaglandin I2 Sales by Type (2027-2032) & (k units) Table 151. China Prostaglandin I2 Sales Price by Type (2021-2026) & (US$/unit) Table 152. China Prostaglandin I2 Sales Price by Type (2027-2032) & (US$/unit) Table 153. China Prostaglandin I2 Revenue by Application (2021-2026) & (US$ Million) Table 154. China Prostaglandin I2 Revenue by Application (2027-2032) & (US$ Million) Table 155. China Prostaglandin I2 Sales by Application (2021-2026) & (k units) Table 156. China Prostaglandin I2 Sales by Application (2027-2032) & (k units) Table 157. China Prostaglandin I2 Sales Price by Application (2021-2026) & (US$/unit) Table 158. China Prostaglandin I2 Sales Price by Application (2027-2032) & (US$/unit) Table 159. Asia Prostaglandin I2 Revenue by Type (2021-2026) & (US$ Million) Table 160. Asia Prostaglandin I2 Revenue by Type (2027-2032) & (US$ Million) Table 161. Asia Prostaglandin I2 Sales by Type (2021-2026) & (k units) Table 162. Asia Prostaglandin I2 Sales by Type (2027-2032) & (k units) Table 163. Asia Prostaglandin I2 Sales Price by Type (2021-2026) & (US$/unit) Table 164. Asia Prostaglandin I2 Sales Price by Type (2027-2032) & (US$/unit) Table 165. Asia Prostaglandin I2 Revenue by Application (2021-2026) & (US$ Million) Table 166. Asia Prostaglandin I2 Revenue by Application (2027-2032) & (US$ Million) Table 167. Asia Prostaglandin I2 Sales by Application (2021-2026) & (k units) Table 168. Asia Prostaglandin I2 Sales by Application (2027-2032) & (k units) Table 169. Asia Prostaglandin I2 Sales Price by Application (2021-2026) & (US$/unit) Table 170. Asia Prostaglandin I2 Sales Price by Application (2027-2032) & (US$/unit) Table 171. Asia Prostaglandin I2 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 172. Asia Prostaglandin I2 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 173. Asia Prostaglandin I2 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 174. Asia Prostaglandin I2 Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 175. Asia Prostaglandin I2 Sales by Country (2021-2026) & (k units) Table 176. Asia Prostaglandin I2 Sales by Country (2027-2032) & (k units) Table 177. Asia Prostaglandin I2 Sales Price by Country (2021-2026) & (US$/unit) Table 178. Asia Prostaglandin I2 Sales Price by Country (2027-2032) & (US$/unit) Table 179. Japan Prostaglandin I2 Revenue (2021-2032) & (US$ Million) Table 180. South Korea Prostaglandin I2 Revenue (2021-2032) & (US$ Million) Table 181. India Prostaglandin I2 Revenue (2021-2032) & (US$ Million) Table 182. Australia Prostaglandin I2 Revenue (2021-2032) & (US$ Million) Table 183. Taiwan Prostaglandin I2 Revenue (2021-2032) & (US$ Million) Table 184. Southeast Asia Prostaglandin I2 Revenue (2021-2032) & (US$ Million) Table 185. SAMEA Prostaglandin I2 Revenue by Type (2021-2026) & (US$ Million) Table 186. SAMEA Prostaglandin I2 Revenue by Type (2027-2032) & (US$ Million) Table 187. SAMEA Prostaglandin I2 Sales by Type (2021-2026) & (k units) Table 188. SAMEA Prostaglandin I2 Sales by Type (2027-2032) & (k units) Table 189. SAMEA Prostaglandin I2 Sales Price by Type (2021-2026) & (US$/unit) Table 190. SAMEA Prostaglandin I2 Sales Price by Type (2027-2032) & (US$/unit) Table 191. SAMEA Prostaglandin I2 Revenue by Application (2021-2026) & (US$ Million) Table 192. SAMEA Prostaglandin I2 Revenue by Application (2027-2032) & (US$ Million) Table 193. SAMEA Prostaglandin I2 Sales by Application (2021-2026) & (k units) Table 194. SAMEA Prostaglandin I2 Sales by Application (2027-2032) & (k units) Table 195. SAMEA Prostaglandin I2 Sales Price by Application (2021-2026) & (US$/unit) Table 196. SAMEA Prostaglandin I2 Sales Price by Application (2027-2032) & (US$/unit) Table 197. SAMEA Prostaglandin I2 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 198. SAMEA Prostaglandin I2 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 199. SAMEA Prostaglandin I2 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 200. SAMEA Prostaglandin I2 Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 201. SAMEA Prostaglandin I2 Sales by Country (2021-2026) & (k units) Table 202. SAMEA Prostaglandin I2 Sales by Country (2027-2032) & (k units) Table 203. SAMEA Prostaglandin I2 Sales Price by Country (2021-2026) & (US$/unit) Table 204. SAMEA Prostaglandin I2 Sales Price by Country (2027-2032) & (US$/unit) Table 205. Brazil Prostaglandin I2 Revenue (2021-2032) & (US$ Million) Table 206. Argentina Prostaglandin I2 Revenue (2021-2032) & (US$ Million) Table 207. Chile Prostaglandin I2 Revenue (2021-2032) & (US$ Million) Table 208. Colombia Prostaglandin I2 Revenue (2021-2032) & (US$ Million) Table 209. Peru Prostaglandin I2 Revenue (2021-2032) & (US$ Million) Table 210. Saudi Arabia Prostaglandin I2 Revenue (2021-2032) & (US$ Million) Table 211. Israel Prostaglandin I2 Revenue (2021-2032) & (US$ Million) Table 212. UAE Prostaglandin I2 Revenue (2021-2032) & (US$ Million) Table 213. Turkey Prostaglandin I2 Revenue (2021-2032) & (US$ Million) Table 214. Iran Prostaglandin I2 Revenue (2021-2032) & (US$ Million) Table 215. Egypt Prostaglandin I2 Revenue (2021-2032) & (US$ Million) Table 216. Key Raw Materials Table 217. Raw Materials Key Suppliers Table 218. Prostaglandin I2 Distributors List Table 219. Prostaglandin I2 Customers List Table 220. Research Programs/Design for This Report Table 221. Authors List of This Report Table 222. Secondary Sources Table 223. Primary Sources List of Figures Figure 1. Prostaglandin I2 Image Figure 2. Global Prostaglandin I2 Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Prostaglandin I2 Market Size Share 2021 VS 2025 VS 2032 Figure 4. Epoprostenol Sodium Image Figure 5. Iloprost Image Figure 6. Treprostinil Image Figure 7. Beraprost Sodium Image Figure 8. Global Prostaglandin I2 Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Prostaglandin I2 Market Size Share 2021 VS 2025 VS 2032 Figure 10. For Oral Image Figure 11. For Inhalation Image Figure 12. For Injection Image Figure 13. Global Prostaglandin I2 Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Prostaglandin I2 Revenue (2021-2032) & (US$ Million) Figure 15. Global Prostaglandin I2 Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Prostaglandin I2 Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Prostaglandin I2 Revenue Market Share by Region (2021-2032) Figure 18. Global Prostaglandin I2 Sales (2021-2032) & (k units) Figure 19. Global Prostaglandin I2 Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 20. Global Prostaglandin I2 Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Prostaglandin I2 Sales YoY (2021-2032) & (k units) Figure 22. Europe Prostaglandin I2 Sales YoY (2021-2032) & (k units) Figure 23. China Prostaglandin I2 Sales YoY (2021-2032) & (k units) Figure 24. Asia (Excluding China) Prostaglandin I2 Sales YoY (2021-2032) & (k units) Figure 25. South America, Middle East and Africa Prostaglandin I2 Sales YoY (2021-2032) & (k units) Figure 26. Global Prostaglandin I2 Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Prostaglandin I2 Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Prostaglandin I2 Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Prostaglandin I2 Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Prostaglandin I2 Revenue Market Share by Type (2021-2032) Figure 32. Global Prostaglandin I2 Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 33. Global Prostaglandin I2 Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Prostaglandin I2 Sales Market Share by Type (2021-2032) Figure 35. Global Prostaglandin I2 Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Prostaglandin I2 Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Prostaglandin I2 Revenue Market Share by Application (2021-2032) Figure 38. Global Prostaglandin I2 Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 39. Global Prostaglandin I2 Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Prostaglandin I2 Sales Market Share by Application (2021-2032) Figure 41. North America Prostaglandin I2 Revenue Share by Type (2021-2032) Figure 42. North America Prostaglandin I2 Sales Share by Type (2021-2032) Figure 43. North America Prostaglandin I2 Revenue Share by Application (2021-2032) Figure 44. North America Prostaglandin I2 Sales Share by Application (2021-2032) Figure 45. North America Prostaglandin I2 Revenue Share by Country (2021-2032) Figure 46. North America Prostaglandin I2 Sales Share by Country (2021-2032) Figure 47. Europe Prostaglandin I2 Revenue Share by Type (2021-2032) Figure 48. Europe Prostaglandin I2 Sales Share by Type (2021-2032) Figure 49. Europe Prostaglandin I2 Revenue Share by Application (2021-2032) Figure 50. Europe Prostaglandin I2 Sales Share by Application (2021-2032) Figure 51. Europe Prostaglandin I2 Revenue Share by Country (2021-2032) Figure 52. Europe Prostaglandin I2 Sales Share by Country (2021-2032) Figure 53. China Prostaglandin I2 Revenue Share by Type (2021-2032) Figure 54. China Prostaglandin I2 Sales Share by Type (2021-2032) Figure 55. China Prostaglandin I2 Revenue Share by Application (2021-2032) Figure 56. China Prostaglandin I2 Sales Share by Application (2021-2032) Figure 57. Asia Prostaglandin I2 Revenue Share by Type (2021-2032) Figure 58. Asia Prostaglandin I2 Sales Share by Type (2021-2032) Figure 59. Asia Prostaglandin I2 Revenue Share by Application (2021-2032) Figure 60. Asia Prostaglandin I2 Sales Share by Application (2021-2032) Figure 61. Asia Prostaglandin I2 Revenue Share by Country (2021-2032) Figure 62. Asia Prostaglandin I2 Sales Share by Country (2021-2032) Figure 63. SAMEA Prostaglandin I2 Revenue Share by Type (2021-2032) Figure 64. SAMEA Prostaglandin I2 Sales Share by Type (2021-2032) Figure 65. SAMEA Prostaglandin I2 Revenue Share by Application (2021-2032) Figure 66. SAMEA Prostaglandin I2 Sales Share by Application (2021-2032) Figure 67. SAMEA Prostaglandin I2 Revenue Share by Country (2021-2032) Figure 68. SAMEA Prostaglandin I2 Sales Share by Country (2021-2032) Figure 69. Prostaglandin I2 Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Prostaglandin I2 Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Epoprostenol Sodium
  • Iloprost
  • Treprostinil
  • Beraprost Sodium
Applications
  • For Oral
  • For Inhalation
  • For Injection
Companies covered
  • Teva
  • J & J
  • GSK
  • Bayer AG
  • United Therapeutics
  • Toray
  • Tide Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Prostaglandin I2 Market by Type
  3. 1.2.1 Global Prostaglandin I2 Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Epoprostenol Sodium
  5. 1.2.3 Iloprost
  6. 1.2.4 Treprostinil
  7. 1.2.5 Beraprost Sodium
  8. 1.3 Prostaglandin I2 Market by Application
  9. 1.3.1 Global Prostaglandin I2 Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 For Oral
  11. 1.3.3 For Inhalation
  12. 1.3.4 For Injection
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Prostaglandin I2 Market Dynamics
  1. 2.1 Prostaglandin I2 Industry Trends
  2. 2.2 Prostaglandin I2 Industry Drivers
  3. 2.3 Prostaglandin I2 Industry Opportunities and Challenges
  4. 2.4 Prostaglandin I2 Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Prostaglandin I2 Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Prostaglandin I2 Revenue by Region
  3. 3.2.1 Global Prostaglandin I2 Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Prostaglandin I2 Revenue by Region (2021-2026)
  5. 3.2.3 Global Prostaglandin I2 Revenue by Region (2027-2032)
  6. 3.2.4 Global Prostaglandin I2 Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Prostaglandin I2 Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Prostaglandin I2 Sales by Region
  9. 3.4.1 Global Prostaglandin I2 Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Prostaglandin I2 Sales by Region (2021-2026)
  11. 3.4.3 Global Prostaglandin I2 Sales by Region (2027-2032)
  12. 3.4.4 Global Prostaglandin I2 Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Prostaglandin I2 Revenue by Manufacturers
  2. 4.1.1 Global Prostaglandin I2 Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Prostaglandin I2 Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Prostaglandin I2 Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Prostaglandin I2 Sales by Manufacturers
  6. 4.2.1 Global Prostaglandin I2 Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Prostaglandin I2 Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Prostaglandin I2 Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Prostaglandin I2 Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Prostaglandin I2 Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Prostaglandin I2 Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Prostaglandin I2 Manufacturers, Product Type & Application
  13. 4.7 Global Prostaglandin I2 Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Prostaglandin I2 Market CR5 and HHI
  16. 4.8.2 2025 Prostaglandin I2 Tier 1, Tier 2, and Tier 3
5 Prostaglandin I2 Market by Type
  1. 5.1 Global Prostaglandin I2 Revenue by Type
  2. 5.1.1 Global Prostaglandin I2 Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Prostaglandin I2 Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Prostaglandin I2 Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Prostaglandin I2 Sales by Type
  6. 5.2.1 Global Prostaglandin I2 Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Prostaglandin I2 Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Prostaglandin I2 Sales Market Share by Type (2021-2032)
  9. 5.3 Global Prostaglandin I2 Price by Type
6 Prostaglandin I2 Market by Application
  1. 6.1 Global Prostaglandin I2 Revenue by Application
  2. 6.1.1 Global Prostaglandin I2 Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Prostaglandin I2 Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Prostaglandin I2 Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Prostaglandin I2 Sales by Application
  6. 6.2.1 Global Prostaglandin I2 Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Prostaglandin I2 Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Prostaglandin I2 Sales Market Share by Application (2021-2032)
  9. 6.3 Global Prostaglandin I2 Price by Application
7 Company Profiles
  1. 7.1 Teva
  2. 7.1.1 Teva Company Information
  3. 7.1.2 Teva Business Overview
  4. 7.1.3 Teva Prostaglandin I2 Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Teva Prostaglandin I2 Product Portfolio
  6. 7.1.5 Teva Recent Developments
  7. 7.2 J & J
  8. 7.2.1 J & J Company Information
  9. 7.2.2 J & J Business Overview
  10. 7.2.3 J & J Prostaglandin I2 Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 J & J Prostaglandin I2 Product Portfolio
  12. 7.2.5 J & J Recent Developments
  13. 7.3 GSK
  14. 7.3.1 GSK Company Information
  15. 7.3.2 GSK Business Overview
  16. 7.3.3 GSK Prostaglandin I2 Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 GSK Prostaglandin I2 Product Portfolio
  18. 7.3.5 GSK Recent Developments
  19. 7.4 Bayer AG
  20. 7.4.1 Bayer AG Company Information
  21. 7.4.2 Bayer AG Business Overview
  22. 7.4.3 Bayer AG Prostaglandin I2 Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Bayer AG Prostaglandin I2 Product Portfolio
  24. 7.4.5 Bayer AG Recent Developments
  25. 7.5 United Therapeutics
  26. 7.5.1 United Therapeutics Company Information
  27. 7.5.2 United Therapeutics Business Overview
  28. 7.5.3 United Therapeutics Prostaglandin I2 Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 United Therapeutics Prostaglandin I2 Product Portfolio
  30. 7.5.5 United Therapeutics Recent Developments
  31. 7.6 Toray
  32. 7.6.1 Toray Company Information
  33. 7.6.2 Toray Business Overview
  34. 7.6.3 Toray Prostaglandin I2 Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Toray Prostaglandin I2 Product Portfolio
  36. 7.6.5 Toray Recent Developments
  37. 7.7 Tide Pharma
  38. 7.7.1 Tide Pharma Company Information
  39. 7.7.2 Tide Pharma Business Overview
  40. 7.7.3 Tide Pharma Prostaglandin I2 Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Tide Pharma Prostaglandin I2 Product Portfolio
  42. 7.7.5 Tide Pharma Recent Developments
8 North America
  1. 8.1 North America Prostaglandin I2 Market Size by Type
  2. 8.1.1 North America Prostaglandin I2 Revenue by Type (2021-2032)
  3. 8.1.2 North America Prostaglandin I2 Sales by Type (2021-2032)
  4. 8.1.3 North America Prostaglandin I2 Price by Type (2021-2032)
  5. 8.2 North America Prostaglandin I2 Market Size by Application
  6. 8.2.1 North America Prostaglandin I2 Revenue by Application (2021-2032)
  7. 8.2.2 North America Prostaglandin I2 Sales by Application (2021-2032)
  8. 8.2.3 North America Prostaglandin I2 Price by Application (2021-2032)
  9. 8.3 North America Prostaglandin I2 Market Size by Country
  10. 8.3.1 North America Prostaglandin I2 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Prostaglandin I2 Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Prostaglandin I2 Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Prostaglandin I2 Market Size by Type
  2. 9.1.1 Europe Prostaglandin I2 Revenue by Type (2021-2032)
  3. 9.1.2 Europe Prostaglandin I2 Sales by Type (2021-2032)
  4. 9.1.3 Europe Prostaglandin I2 Price by Type (2021-2032)
  5. 9.2 Europe Prostaglandin I2 Market Size by Application
  6. 9.2.1 Europe Prostaglandin I2 Revenue by Application (2021-2032)
  7. 9.2.2 Europe Prostaglandin I2 Sales by Application (2021-2032)
  8. 9.2.3 Europe Prostaglandin I2 Price by Application (2021-2032)
  9. 9.3 Europe Prostaglandin I2 Market Size by Country
  10. 9.3.1 Europe Prostaglandin I2 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Prostaglandin I2 Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Prostaglandin I2 Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Prostaglandin I2 Market Size by Type
  2. 10.1.1 China Prostaglandin I2 Revenue by Type (2021-2032)
  3. 10.1.2 China Prostaglandin I2 Sales by Type (2021-2032)
  4. 10.1.3 China Prostaglandin I2 Price by Type (2021-2032)
  5. 10.2 China Prostaglandin I2 Market Size by Application
  6. 10.2.1 China Prostaglandin I2 Revenue by Application (2021-2032)
  7. 10.2.2 China Prostaglandin I2 Sales by Application (2021-2032)
  8. 10.2.3 China Prostaglandin I2 Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Prostaglandin I2 Market Size by Type
  2. 11.1.1 Asia Prostaglandin I2 Revenue by Type (2021-2032)
  3. 11.1.2 Asia Prostaglandin I2 Sales by Type (2021-2032)
  4. 11.1.3 Asia Prostaglandin I2 Price by Type (2021-2032)
  5. 11.2 Asia Prostaglandin I2 Market Size by Application
  6. 11.2.1 Asia Prostaglandin I2 Revenue by Application (2021-2032)
  7. 11.2.2 Asia Prostaglandin I2 Sales by Application (2021-2032)
  8. 11.2.3 Asia Prostaglandin I2 Price by Application (2021-2032)
  9. 11.3 Asia Prostaglandin I2 Market Size by Country
  10. 11.3.1 Asia Prostaglandin I2 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Prostaglandin I2 Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Prostaglandin I2 Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Prostaglandin I2 Market Size by Type
  2. 12.1.1 SAMEA Prostaglandin I2 Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Prostaglandin I2 Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Prostaglandin I2 Price by Type (2021-2032)
  5. 12.2 SAMEA Prostaglandin I2 Market Size by Application
  6. 12.2.1 SAMEA Prostaglandin I2 Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Prostaglandin I2 Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Prostaglandin I2 Price by Application (2021-2032)
  9. 12.3 SAMEA Prostaglandin I2 Market Size by Country
  10. 12.3.1 SAMEA Prostaglandin I2 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Prostaglandin I2 Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Prostaglandin I2 Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Prostaglandin I2 Value Chain Analysis
  2. 13.1.1 Prostaglandin I2 Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Prostaglandin I2 Production Mode & Process
  6. 13.2 Prostaglandin I2 Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Prostaglandin I2 Distributors
  9. 13.2.3 Prostaglandin I2 Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research